AI assistant
Cocoon Holdings Limited — Proxy Solicitation & Information Statement 2021
Mar 5, 2021
49210_rns_2021-03-05_31d68120-1302-482f-8e58-3e44c01ad521.pdf
Proxy Solicitation & Information Statement
Open in viewerOpens in your device viewer
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
==> picture [76 x 32] intentionally omitted <==
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED 阿里健康信息技術有限公司
(Incorporated in Bermuda with limited liability)
(Stock code: 00241)
NOTICE OF SPECIAL GENERAL MEETING
Notice is hereby given that a special general meeting (the ‘‘SGM’’) of Alibaba Health Information Technology Limited (the ‘‘Company’’) will be held at Holiday Inn Express Hong Kong Causeway Bay, Meeting Room I & II, 7/F., 33 Sharp Street East, Causeway Bay, Hong Kong on Monday, March 29, 2021 at 2: 30 p.m. for the purposes of considering and, if thought fit, passing (with or without amendments) the following ordinary resolutions:
ORDINARY RESOLUTIONS
‘‘THAT
-
the 2022 logistics services framework agreement entered into between the Company and Hangzhou Cainiao Supply Chain Management Co., Ltd* (杭州菜鳥供應鏈管理 有限公司) on February 5, 2021, the continuing connected transactions contemplated thereunder and the proposed annual cap for the year ending March 31, 2022, be and are hereby confirmed, approved and ratified;
-
the 2022 platform services framework agreement entered into between the Company and Alibaba Group Holding Limited (‘‘Alibaba Holding’’) on February 5, 2021, the continuing connected transactions contemplated thereunder and the proposed annual cap for the year ending March 31, 2022, be and are hereby confirmed, approved and ratified;
-
the 2022 advertising services framework agreement entered into between the Company and Alibaba Holding on February 5, 2021, the continuing connected transactions contemplated thereunder and the proposed annual cap for the year ending March 31, 2022, be and are hereby confirmed, approved and ratified;
– 1 –
-
the 2022 framework technical services agreement entered into between Alibaba Health Technology (Hangzhou) Co., Ltd. (阿里健康科技(杭州)有限公司), Alibaba Health Technology (Hainan) Co., Ltd. (阿里健康科技(海南)有限公司) and the Tmall Entities (namely, Zhejiang Tmall Technology Co., Ltd. (浙江天貓技術有限公 司), Zhejiang Tmall Network Co., Ltd. (浙江天貓網絡有限公司) and/or their applicable affiliates (as the case may be), collectively) on February 5, 2021, the continuing connected transactions contemplated thereunder and the proposed annual cap for the year ending March 31, 2022, be and are hereby confirmed, approved and ratified; and
-
any one or more of the directors of the Company (the ‘‘Directors’’) for and on behalf of the Company be and are hereby authorized to sign, seal, execute and deliver all such documents and deeds, and do all such acts, matters and things as they may in their discretion consider necessary, desirable or expedient to give effect to and/or to implement the transactions contemplated in the Resolutions 1 to 4.’’
By Order of the Board
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED ZHU Shunyan Chief Executive Officer and Executive Director
Hong Kong, March 8, 2021
Notes:
-
All resolutions at the SGM will be taken by poll pursuant to the bye-laws of the Company and the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the ‘‘Listing Rules’’) and the results of the poll will be published on the websites of Hong Kong Exchanges and Clearing Limited and the Company in accordance with the Listing Rules.
-
Any shareholder of the Company entitled to attend and vote at the SGM is entitled to appoint a proxy to attend and vote instead of him/her. A proxy needs not be a shareholder of the Company. If more than one proxy is so appointed, the appointment shall specify the number and class of shares in respect of which each such proxy is so appointed.
-
Any shareholder of the Company whose ownership is either recorded through the Central Clearing and Settlement System (CCASS) or maintained with a licensed securities dealer (i.e., not directly recorded in his/her own name in the Register of Members of the Company) shall only be entitled to vote by providing his/her instructions to vote to HKSCC Nominees Limited either directly as a CCASS Participant or through his/her licensed securities dealer and the relevant financial intermediaries. In order to attend and vote at the SGM, any such shareholder shall be appointed by HKSCC Nominees Limited as its proxy to attend and vote instead of him/her.
-
In order to be valid, the form of proxy must be deposited at the Company’s Hong Kong branch share registrar, Tricor Secretaries Limited, at Level 54, Hopewell Centre, 183 Queen’s Road East, Hong Kong, not less than 48 hours before the time appointed for the holding of the SGM or any adjournment thereof. Delivery of the form of proxy shall not preclude a shareholder of the Company from attending and voting in person at the SGM and, in such event, the instrument appointing a proxy shall be deemed to be revoked.
– 2 –
-
The record date for determining the entitlement of the shareholders of the Company to attend and vote at the above meeting will be Tuesday, March 23, 2021. All transfers of shares of the Company accompanied by the relevant share certificates must be lodged with the Company’s Hong Kong branch share registrar, Tricor Secretaries Limited, at Level 54, Hopewell Centre, 183 Queen’s Road East, Hong Kong, for registration no later than 4: 30 p.m. on Tuesday, March 23, 2021.
-
In the event of inconsistency, the English text of this announcement shall prevail over the Chinese text.
-
As at the date of this announcement, the Board comprises seven Directors, of whom (i) two are executive Directors, namely Mr. ZHU Shunyan and Mr. TU Yanwu; (ii) two are non-executive Directors, namely Mr. WU Yongming and Mr. XU Hong; and (iii) three are independent non-executive Directors, namely Mr. LUO Tong, Mr. WONG King On, Samuel and Ms. HUANG Yi Fei (Vanessa).
-
English name for identification purpose only.
– 3 –